B-prolymphocytic leukemia: Is it time to retire this entity?

El Hussein, Siba; Khoury, Joseph D; Medeiros, L Jeffrey

El Hussein, Siba; Khoury, Joseph D; Medeiros, L Jeffrey.

Affiliation

El Hussein S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: ljmedeiros@mdanderson.org.

Ann Diagn Pathol ; 54: 151790, 2021 Oct.

Article in En | MEDLINE | ID: mdl-34293709

Subject(s)

Leukemia, Prolymphocytic, B-Cell/diagnosis; Leukemia, Prolymphocytic, B-Cell/pathology; Lymphocytes/pathology; Cell Transformation, Neoplastic/pathology; Humans; Immunophenotyping/methods; Leukemia, Prolymphocytic, B-Cell/epidemiology; Lymphoma, B-Cell/pathology

Key words

B-PLL; B-prolymphocytic leukemia; Prolymphocytes; Prolymphocytoid; Review; Small B-cell lymphoma; Transformation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphocytes / Leukemia, Prolymphocytic, B-Cell Limits: Humans Language: En Journal: Ann Diagn Pathol Journal subject: PATOLOGIA Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google